Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This early-phase trial tests a new treatment for people with advanced melanoma or other solid tumors that have spread. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The goal is to find a safe dose and see if t…
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated May 16, 2026 22:31 UTC